| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gritstone bio, Inc. | Director | Common Stock | 25K | $47.6K | $1.90 | Apr 26, 2024 | Direct |
| Nabriva Therapeutics plc | Director | Ordinary Shares | 11.4K | $17.2K | $1.50 | Aug 2, 2022 | Direct |
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 18.7K | Jun 20, 2024 | Direct | ||
| Cullinan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15.8K | Jun 26, 2024 | Direct | ||
| Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 7.38K | Jun 17, 2024 | Direct | ||
| TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.74 | Jun 1, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| NXTC | NextCure, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| GRTS | Gritstone bio, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
| GRTS | Gritstone bio, Inc. | Apr 26, 2024 | 1 | $0 | 4 | Apr 30, 2024 | Director |
| GRTS | Gritstone bio, Inc. | Apr 26, 2024 | 0 | $0 | 3 | Apr 30, 2024 | Director |
| NXTC | NextCure, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| CGEM | Cullinan Oncology, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| TCRR | TCR2 THERAPEUTICS INC. | Jun 1, 2023 | 4 | $0 | 4 | Jun 1, 2023 | Director |
| TCRR | TCR2 THERAPEUTICS INC. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
| NBRV | Nabriva Therapeutics plc | Aug 2, 2022 | 1 | -$1.49K | 4 | Aug 4, 2022 | Director |
| NXTC | NextCure, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| CGEM | Cullinan Oncology, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
| TCRR | TCR2 THERAPEUTICS INC. | Dec 9, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Director |
| CGEM | Cullinan Oncology, Inc. | Sep 16, 2021 | 1 | $0 | 4 | Mar 25, 2022 | Director |
| NBRV | Nabriva Therapeutics plc | Aug 2, 2021 | 1 | -$932 | 4 | Aug 4, 2021 | Director |
| NBRV | Nabriva Therapeutics plc | Jul 28, 2021 | 2 | $0 | 4 | Jul 30, 2021 | Director |
| NXTC | NextCure, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |